FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2009905596> ?p ?o ?g. }

• W2009905596 endingPage "12" @default.
• W2009905596 startingPage "1" @default.
• W2009905596 abstract "Abstract Tumour angiogenesis is essential for cancer growth and metastasis. Many new pathways have been recognised in the last few years, including genes involved in embryonic development of the vasculature, e.g. the notch/delta, ephrin/eph and the HOX genes. Furthermore, vascular mimicry, intussusception and recruitment of circulating endothelial cells may contribute to tumour vessels, as well as endothelial proliferation. A close link has emerged between hypoxia and the regulation of angiogenesis, with many angiogenic factors involved in hypoxia in endothelial cells and cancer cells. Examples include vascular endothelial growth factor (VEGF), platelet-derived growth factor (PDGF), adrenomedullin, oxygen-regulated protein 150, tumour necrosis factor (TNF) alpha, endothelins. Conversely, anti-angiogenic molecules such as thrombospondin are downregulated. The main pathway regulating these responses seems to be via the hypoxia inducible factor I alpha and its modulation by proline hydroxylases. Many oncogenes amplify the effects of the hypoxia pathway, e.g. PTEN mutations. Thus, a plethora of targets is now available for therapy. Most tumours express many different pathways, but some key ones are emerging. VEGF seems to be a core factor for endothelial growth, and blockade of hypoxia signalling also inhibits angiogenesis. One of the difficulties in assessing response to therapy, if only new vessels are inhibited, is that only small amounts of regression may occur. However, clinical trials are now incorporating pharmacodynamic measurements such as vascular permeability and responses have been reported for a wide range of anti-angiogenic agents, in particular the VEGF pathway inhibitors. Marked synergy with conventional treatment modalities has been shown in preclinical models and this paradigm is being followed in clinical trial development. Second generation drugs are now entering phase III trials and are likely to enter routine practice." @default.
• W2009905596 created "2016-06-24" @default.
• W2009905596 creator A5079633934 @default.
• W2009905596 date "2003-09-01" @default.
• W2009905596 modified "2023-09-30" @default.
• W2009905596 title "Angiogenesis as a new target for cancer control" @default.
• W2009905596 cites W1498587827 @default.
• W2009905596 cites W1499075785 @default.
• W2009905596 cites W1516410466 @default.
• W2009905596 cites W1549576586 @default.
• W2009905596 cites W1579297325 @default.
• W2009905596 cites W1580865462 @default.
• W2009905596 cites W1587947784 @default.
• W2009905596 cites W1749022239 @default.
• W2009905596 cites W1966213291 @default.
• W2009905596 cites W1967972966 @default.
• W2009905596 cites W1968539943 @default.
• W2009905596 cites W1968673560 @default.
• W2009905596 cites W1970909475 @default.
• W2009905596 cites W1978471137 @default.
• W2009905596 cites W1980556333 @default.
• W2009905596 cites W1983015953 @default.
• W2009905596 cites W1985804036 @default.
• W2009905596 cites W1988307856 @default.
• W2009905596 cites W1990036692 @default.
• W2009905596 cites W1993363047 @default.
• W2009905596 cites W1995483670 @default.
• W2009905596 cites W2002401594 @default.
• W2009905596 cites W2002743235 @default.
• W2009905596 cites W2005868568 @default.
• W2009905596 cites W2007845211 @default.
• W2009905596 cites W2009240587 @default.
• W2009905596 cites W2010127368 @default.
• W2009905596 cites W2010589579 @default.
• W2009905596 cites W2013631005 @default.
• W2009905596 cites W2014927326 @default.
• W2009905596 cites W2015353751 @default.
• W2009905596 cites W2015809080 @default.
• W2009905596 cites W2025041219 @default.
• W2009905596 cites W2025418258 @default.
• W2009905596 cites W2025532009 @default.
• W2009905596 cites W2029883816 @default.
• W2009905596 cites W2031696262 @default.
• W2009905596 cites W2040031153 @default.
• W2009905596 cites W2040830176 @default.
• W2009905596 cites W2041905383 @default.
• W2009905596 cites W2042216712 @default.
• W2009905596 cites W2045070437 @default.
• W2009905596 cites W2048306047 @default.
• W2009905596 cites W2049466721 @default.
• W2009905596 cites W2051984245 @default.
• W2009905596 cites W2054119278 @default.
• W2009905596 cites W2063076489 @default.
• W2009905596 cites W2063354005 @default.
• W2009905596 cites W2067958384 @default.
• W2009905596 cites W2069698188 @default.
• W2009905596 cites W2069937695 @default.
• W2009905596 cites W2070264012 @default.
• W2009905596 cites W2071080900 @default.
• W2009905596 cites W2072928113 @default.
• W2009905596 cites W2075880681 @default.
• W2009905596 cites W2076211846 @default.
• W2009905596 cites W2078247661 @default.
• W2009905596 cites W2078766485 @default.
• W2009905596 cites W2079729042 @default.
• W2009905596 cites W2081327537 @default.
• W2009905596 cites W2082133442 @default.
• W2009905596 cites W2085896636 @default.
• W2009905596 cites W2092305222 @default.
• W2009905596 cites W2093280246 @default.
• W2009905596 cites W2094420450 @default.
• W2009905596 cites W2094901288 @default.
• W2009905596 cites W2098273775 @default.
• W2009905596 cites W2101514446 @default.
• W2009905596 cites W2111796479 @default.
• W2009905596 cites W2113001776 @default.
• W2009905596 cites W2113551024 @default.
• W2009905596 cites W2115322318 @default.
• W2009905596 cites W2116512864 @default.
• W2009905596 cites W2125257427 @default.
• W2009905596 cites W2131393213 @default.
• W2009905596 cites W2131762447 @default.
• W2009905596 cites W2131798870 @default.
• W2009905596 cites W2132482143 @default.
• W2009905596 cites W2134648032 @default.
• W2009905596 cites W2134674686 @default.
• W2009905596 cites W2136242764 @default.
• W2009905596 cites W2138178479 @default.
• W2009905596 cites W2140403987 @default.
• W2009905596 cites W2141046053 @default.
• W2009905596 cites W2141851994 @default.
• W2009905596 cites W2144625075 @default.
• W2009905596 cites W2145639716 @default.
• W2009905596 cites W2147718842 @default.
• W2009905596 cites W2149268957 @default.
• W2009905596 cites W2152326461 @default.
• W2009905596 cites W2157172418 @default.
• W2009905596 cites W2158134782 @default.

• next